1. Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication. Issue 1 (24th June 2020) Authors: Flores, Erica B; Aksoy, Bulent A; Bartee, Eric Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗